Foralumab is the first intranasal immune modulator in clinical trials for patients with Multiple System AtrophyBOSTON, May 14, 2026 (GLOBE NEWSWIRE) -- Tiziana Life Sciences, Ltd. (Nasdaq: TLSA) ...

The first participant has been dosed in an investigator-led Phase 2 trial testing pegsebrenatide as a potential treatment for ...

Ms Gwyn Lim Qi Zheng (right) was one of the recipients of Temasek Polytechnic's Ngee Ann Kongsi Most Outstanding Overcomer ...

See the latest news from Your World at https://www.sussexexpress.co.uk/your-world ...

Learn how certain conditions, contraceptives, lifestyle factors, and more can cause recurrent urinary tract infections and UTI-like symptoms.

A 16-year MRI study reveals that lower visceral fat is linked to slower brain atrophy and better cognition, mediated by ...

Two experimental drug molecules promoted myelin repair in MS disease models, pointing toward a possible future route for ...

DNA damage from inflammation outpaces the cells’ ability to self-repair. The finding, in human brain cells and mice, could ...

A new type of MRI scan may distinguish active from chronic MS lesions without the need for injected contrast dye.

Peer-reviewed study from the bioMUSE Natural History Study shows advanced MRI method detects disease-specific iron accumulation that supports ...

A next-generation cancer therapy being developed at McMaster University has shown early promise as a treatment candidate for ...